ManishaCBalwaniMD

PubMed

• Case-based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management.
  Siobán Keel, Peter Meissner, Mark Sonderup, Penelope Stein, Makiko Yasuda, Manisha Balwani> ;Liver International. 2024 Apr 15
• Regression of smoldering myeloma with treatment of Gaucher disease.
  Kevin Barley, Anshuman Parekh, Deepa Vatti, Daniel Verina, Violetta V Leshchenko, Sundar Jagannath, Manisha Balwani, Syed Salam, Damodara Rao Mendu, Ravi Prakash Shukl...> ;Blood Advances. 2024 Apr 9
• Reply: Contrasting effect of iron supplementation in protoporphyria.
  Cynthia Levy, Amy K Dickey, Karl E Anderson, Sioban B Keel, Manisha Balwani> ;Hepatology. 2024 Mar 1
• 2 citations
  Update on the Porphyrias.
  Amy K Dickey, Rebecca Karp Leaf, Manisha Balwani> ;Annual Review of Medicine. 2024 Jan 29
• 1 citations
  Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protopor...
  Cynthia Levy, Amy K Dickey, Bruce Wang, Manish Thapar, Hetanshi Naik, Siobán B Keel, Behnam Saberi, Simon W Beaven, Sean R Rudnick, Sarina B Elmariah, Angelika L Erwin...> ;Hepatology. 2024 Mar 1
• Lysosomal acid lipase deficiency manifestations in children and adults: Baseline data from an international registry.
  Manisha Balwani, William Balistreri, Lorenzo D'Antiga, Jennifer Evans, Emilio Ros, Florian Abel, Don P Wilson> ;Liver International. 2023 Jul 1
• The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substr...
  Pramod K Mistry, Priya S Kishnani, Manisha Balwani, Joel M Charrow, Judy Hull, Neal J Weinreb, Timothy M Cox> ;Journal of Clinical Medicine. 2023 May 4
• RNA interference therapy in acute hepatic porphyrias.
  Makiko Yasuda, Siobán Keel, Manisha Balwani> ;Blood. 2023 Nov 9
• 5 citations
  Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease.
  Cornelis Blauwendraat, Nahid Tayebi, Elizabeth Geena Woo, Grisel Lopez, Luca Fierro, Marco Toffoli, Naomi Limbachiya, Derralynn Hughes, Vanessa Pitz, Dhairya Patel, Da...> ;Movement Disorders. 2023 May 1
• 4 citations
  AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
  Bruce Wang, Herbert L Bonkovsky, Joseph K Lim, Manisha Balwani> ;Gastroenterology. 2023 Mar 1
• A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria.
  Manisha Balwani, Hetanshi Naik, Jessica R Overbey, Herbert L Bonkovsky, D Montgomery Bissell, Bruce Wang, John D Phillips, Robert J Desnick, Karl E Anderson> ;Molecular Genetics and Metabolism Reports. 2022 Dec 1
• 6 citations
  Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran.
  Paolo Ventura, Eliane Sardh, Nicola Longo, Manisha Balwani, Jorge Plutzky, Laurent Gouya, John Phillips, Sean Rhyee, Mary-Jean Fanelli, Marianne T Sweetser, Petro E Pe...> ;Expert Review of Gastroenterology & Hepatology. 2022 Sep 1
• 5 citations
  Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria.
  Amy K Dickey, Hetanshi Naik, Siobán B Keel, Cynthia Levy, Simon W Beaven, Sarina B Elmariah, Angelika L Erwin, Robert J Goddu, Karli Hedstrom, Rebecca K Leaf, Mohamed ...> ;Journal of the American Academy of Dermatology. 2023 Dec 1
• 7 citations
  Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.
  Bruce Wang, Paolo Ventura, Kei-Ichiro Takase, Manish Thapar, David Cassiman, Ilja Kubisch, Shangbin Liu, Marianne T Sweetser, Manisha Balwani> ;Orphanet Journal of Rare Diseases. 2022 Aug 26
• Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?
  Matthew Surface, Manisha Balwani, Cheryl Waters, Alexander Haimovich, Ziv Gan-Or, Karen S Marder, Tammy Hsieh, Linxia Song, Shalini Padmanabhan, Frank Hsieh, Kalpana M...> ;Movement Disorders. 2022 Aug 1
• 1 citations
  A 51-Year-Old Woman With Interstitial Lung Disease and Subsequent COVID-19 Presenting With Worsening Dyspnea.
  Nicole Ng, Jigna Zatakia, Mary B Beasley, Michael Chung, Manisha Balwani, Chanan Stauffer, Edward H Schuchman, Sakshi Dua> ;Chest. 2022 Jul 1
• 1 citations
  Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease.
  Matthew Surface, Manisha Balwani, Cheryl Waters, Alexander Haimovich, Ziv Gan-Or, Karen S Marder, Tammy Hsieh, Linxia Song, Shalini Padmanabhan, Frank Hsieh, Kalpana M...> ;Movement Disorders. 2022 Mar 1
• 8 citations
  Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensus.
  Priya S Kishnani, Walla Al-Hertani, Manisha Balwani, Özlem Göker-Alpan, Heather A Lau, Melissa Wasserstein, Neal J Weinreb, Gregory Grabowski> ;Molecular Genetics and Metabolism. 2022 Feb 1
• 10 citations
  SEBELIPASE ALFA IN CHILDREN AND ADULTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY: FINAL RESULTS OF THE ARISE STUDY.
  Barbara K. Burton, François Feillet, Katryn N. Furuya, Sachin Marulkar, Manisha Balwani> ;Journal of Hepatology. 2021 Nov 10
• 22 citations
  Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
  Matthew Surface, Manisha Balwani, Cheryl Waters, Alexander Haimovich, Ziv Gan-Or, Karen Marder, Tammy Hsieh, Linxia Song, Shalini Padmanabhan, Frank Hsieh, Kalpana Mer...> ;Movement Disorders. 2021 Nov 6
• 34 citations
  Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study
  Paolo Ventura, Herbert L. Bonkovsky, Laurent Gouya, Paula Aguilera-Peiró, D. Montgomery Bissell, Penelope E. Stein, Manisha Balwani, D Karl E Anderson, Charles J. Park...> ;Liver International. 2021 Oct 30
• 7 citations
  Porphyrias in the Age of Targeted Therapies.
  Angelika L. Erwin, Manisha Balwani> ;Diagnostics. 2021 Sep 29
• 19 citations
  Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.
  Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, Suma P. Shankar, Hagit Baris Feldman, Marwan Ghosn, Atul Mehta, Seymour Packman, Heather Lau, Milan Petakov, Sarit ...> ;American Journal of Hematology. 2021 Sep 1
• 4 citations
  The clinical spectrum of SARS-CoV-2 infection in Gaucher disease: Effect of both a pandemic and a rare disease that disrupts the immune system.
  Praveena Narayanan, Shiny Nair, Manisha Balwani, Maricar Malinis, Pramod K. Mistry> ;Molecular Genetics and Metabolism. 2021 Aug 13
• 3 citations
  Porphyria attacks in prepubertal children and adolescents.
  Daniel A. Jaramillo-Calle, Yuliana A. Martinez, Manisha Balwani, Camila Fernandez, Martín Toro> ;Molecular Genetics and Metabolism. 2021 May 7
• Join now to see all